Showing all 2 results
Ivabradine HCL Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Ivabradine (as Hydrochloride) USP/Ph.Eur. 5 mg Initiation / Titration Standard: Base therapeutic unit utilized twice daily for the safe initiation of therapy, allowing the cardiologist to monitor resting heart rate before upward titration. Ivabradine (as Hydrochloride) USP/Ph.Eur. 7.5 mg Global Maintenance Standard: High-efficacy adult maintenance dose to strictly maintain the resting heart rate between 50 and 60 beats per minute. Excipients Lactose Monohydrate / Maize Starch / Maltodextrin / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Glidant / Lubricant / Film-Coating (Engineered specifically using precise geometric dilution to ensure the micro-dose API is flawlessly distributed, preventing accidental bradycardia from “hot spots” in a poorly blended generic tablet) *Pack Sizes: 10×10 Blisters or Bottles of 56 (Optimized specifically for strict 28-day chronic cardiology dispensing regimens).
Sacubutril + Valsartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive dual-molecule complex.
Active Ingredient Strength (Total Dose) Primary Clinical Function Sacubitril / Valsartan INN/Ph.Eur. 24 mg / 26 mg (50 mg Total) Starting dose for patients with severe renal impairment, hepatic impairment, or those not currently taking an ACEi/ARB. Sacubitril / Valsartan INN/Ph.Eur. 49 mg / 51 mg (100 mg Total) Standard Initiation Dose: For patients switching from standard doses of ACE inhibitors or ARBs. Sacubitril / Valsartan INN/Ph.Eur. 97 mg / 103 mg (200 mg Total) Target Maintenance Dose: Maximum adult therapy for optimal mortality reduction in heart failure. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 14×2 or 28-Tablet Alu-Alu Blisters (Optimized specifically for strict twice-daily chronic cardiology dispensing regimens).
